大塚ＨＤ（4578）　Otsuka and Lundbeck to Start Third Phase 3 Trial in June to Evaluate Brexpiprazole in the Treatment of Agitation in Patients with Alzheimer's Disease 2018/05/24
/-
読み込み中…